The Ohio Board of Pharmacy withdrew a rule preventing the use of hydroxychloroquine to treat COVID-19 after Governor Mike DeWine called on the board to halt the rule, according to the Dayton Daily News.
“As a result of the feedback received by the medical and patient community and at the request of Gov. DeWine, the State of Ohio Board of Pharmacy has withdrawn proposed rule 4729:5-5-21 of the Administrative Code,” reads a Thursday statement from the board.
“Therefore, prohibitions on the prescribing of chloroquine and hydroxychloroquine in Ohio for the treatment of COVID-19 will not take effect at this time.”
The board will reexamine the rule with the help of the State Medical Board of Ohio, clinical experts and stakeholders to determine the next step.
The rule, which was scheduled to go into effect today, would prohibit pharmacies from selling or dispensing hydroxychloroquine and chloroquine for coronavirus unless the use is approved by the board’s executive director. The rule would also void all previous approvals of the drug. –Dayton Daily News
On Thursday, DeWine said that he agreed with FDA commissioner Stephen Hahn, who said that the decision to use HCQ should be between doctor and patient….